Lipid Multiparticulates (LMPs) are round, smooth matrix multiparticulates, typically 50-1,200 μm in diameter depending on the method of manufacture, which consist of one or more GRAS lipid excipients that are solid at room temperature. LMP technology has the capacity to combine a breadth of functionality with a range of finished dosage formats — capsules, sachets, suspensions and tablets. Capsugel has developed novel LMP technology based on a proprietary melt-spray-congeal process. This innovative drug delivery approach, which has market precedence, can be used for taste-masking, extended release and bioavailability enhancement for pharmaceutical, health and nutritional products.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.